200
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Influencing Factors of Treatment Outcomes Among Patients with Pulmonary Tuberculosis: A Structural Equation Model Approach

ORCID Icon, , , , , ORCID Icon & show all
Pages 2989-2999 | Received 04 May 2023, Accepted 09 Jul 2023, Published online: 04 Aug 2023

References

  • Zhan Y, Wang Y, Zhang W, Ying B, Wang CJJo CM. Diagnostic accuracy of the artificial intelligence methods in medical imaging for pulmonary tuberculosis: a systematic review and meta-analysis. J Clin Med. 2022;12(1):303. doi:10.3390/jcm12010303
  • Organization GWH. Global Tuberculosis Report 2022. Organization GWH; 2022.
  • Bloom BR, Atun R, Cohen T, et al. Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. Washington (DC): The International Bank for Reconstruction and Development / The World Bank © 2017 International Bank for Reconstruction and Development / The World Bank; 2017.
  • Rouf A, Masoodi MA, Dar MM, Khan SMS, Bilquise R. Depression among Tuberculosis patients and its association with treatment outcomes in district Srinagar. J Clin Tuberc Other Mycobact Dis. 2021;25:100281. PMID: 34888421; PMCID: PMCPMC8637130. doi:10.1016/j.jctube.2021.100281
  • Koo HK, Min J, Kim HW, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20(1):622. PMID: 32831044; PMCID: PMCPMC7446045. doi:10.1186/s12879-020-05350-7
  • Daly M, Robinson E. Depression and anxiety during COVID-19. Lancet. 2022;399(10324):518. PMID: 35123689; PMCID: PMCPMC8813060. doi:10.1016/s0140-6736(22)00187-8
  • Méchaï F, Bachelet D, Han L, et al. Tuberculosis treatment outcomes among precarious patients in France. Infect Dis. 2022;52(7):389–395. PMID: 36064101. doi:10.1016/j.idnow.2022.08.004
  • Liu K, Ai L, Pan J, et al. Survival analysis and associated factors for pulmonary tuberculosis death: evidence from the information system of tuberculosis disease and mortality surveillance in China. Risk Manag Healthc Policy. 2022;15:1167–1178. PMID: 35669895; PMCID: PMCPMC9166951. doi:10.2147/rmhp.S368593
  • Brunner J, Austin PC. Inflation of Type I error rate in multiple regression when independent variables are measured with error. Can J Stat. 2009;37(1):33–46. doi:10.1002/cjs.10004
  • Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401. doi:10.1177/014662167700100306
  • Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–379. doi:10.1016/S0033-3182(71)71479-0
  • Jie Zhang ZW, Ge F, Juan L, Han B, Chen Z. Development of the Chinese age norms of CES-D in urban area. Chin Ment Health J. 2010;24(2):139–143.
  • Commission NHaFP. Classification of Tuberculosis. Beijing: National Health and Family Planning Commission; 2018.
  • China MoPHo. China: Diagnostic Criteria for Pulmonary Tuberculosis. Beijing: People’s Medical Publishing House; 2008.
  • Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6(1):1–55. doi:10.1080/10705519909540118
  • Kenny DA, McCoach DB. Effect of the number of variables on measures of fit in structural equation modeling. Struct Equ Model. 2003;10:333–351. doi:10.1207/S15328007SEM1003_1
  • Yu Y, Wu B, Wu C, Wang Q, Hu D, Chen W. Spatial-temporal analysis of tuberculosis in Chongqing, China 2011–2018. BMC Infect Dis. 2020;20(1):531. doi:10.1186/s12879-020-05249-3
  • Lal AA, Rapose A, Rapose A. Latent tuberculosis infection: treatment initiation and completion rates in persons seeking immigration and health care workers. Am J Med. 2019;132(11):1353–1355. doi:10.1016/j.amjmed.2019.04.036
  • Zhi-ping Z, Xian-xiang LI, Yu-feng WEN, Chao J, Yu Z. Analysis of drug resistance characteristic of 342 sputum culture positive pulmonary tuberculosis. Prev Med. 2015;42(03):522–525.
  • Jaiswal A, Ogden JA, Porter JD, et al. Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003;8(7):625–633. doi:10.1046/j.1365-3156.2003.01061.x
  • Garner P, Munro S, Volmink J. Promoting adherence to tuberculosis treatment. Bull World Health Organ. 2007;85(5):404–406. PMCID: PMC PMC2636642. doi:10.2471/blt.06.035568
  • Ruiz P, Zamudio C, Canaza L, Otero L, Kruger H, Seas C. Association of major depressive episode with negative outcomes of tuberculosis treatment. PLoS One. 2013;8(7):e69514. PMCID: PMCPMC3726639. doi:10.1371/journal.pone.0069514
  • Naidoo P, Dick J, Cooper D. Exploring tuberculosis patients’ adherence to treatment regimens and prevention programs at a public health site. Qual Health Res. 2009;19(1):55–70. PMID: WOS:000261732300006. doi:10.1177/1049732308327893
  • Dos Santos AP, Lazzari TK, Silva DR. Health-related quality of life, depression and anxiety in hospitalized patients with tuberculosis. Tuberc Respir Dis. 2017;80(1):69–76. PMID: 28119749; PMCID: PMCPMC5256348. doi:10.4046/trd.2017.80.1.69
  • Aghanwa HS, Erhabor GE. Demographic/socioeconomic factors in mental disorders associated with tuberculosis in southwest Nigeria. J Psychosom Res. 1998;45(4):353–360. PMID: WOS:000075755100006. doi:10.1016/S0022-3999(98)00006-3
  • Westaway MS, Wolmarans L. Depression and self-esteem: rapid screening for depression in black, low literacy, hospitalized tuberculosis patients. Soc Sci Med. 1992;35(10):1311–1315. PMID: 1439914. doi:10.1016/0277-9536(92)90184-r
  • Qiu L, Yang Q, Tong Y, Lu Z, Gong Y, Yin X. The mediating effects of stigma on depressive symptoms in patients with tuberculosis: a structural equation modeling approach. Front Psychiatry. 2018;9:618. PMID: 30534088; PMCID: PMCPMC6275230. doi:10.3389/fpsyt.2018.00618
  • Santomauro DF, Herrera AMM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. PMID: WOS:000715856000024. doi:10.1016/S0140-6736(21)02143-7
  • Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763–1775. PMID: 24525439; PMCID: PMCPMC4040181. doi:10.1183/09031936.00193413
  • Liu Y, Xu CH, Wang XM, et al. Out-of-pocket payments and economic consequences from tuberculosis care in eastern China: income inequality. Infect Dis Poverty. 2020;9(1):14. PMID: 32019611; PMCID: PMCPMC7001258. doi:10.1186/s40249-020-0623-8
  • Sangsang Qiu HL, Zhang S, Jiang W, Huang L, Wang J. Comparative study on the economic burden of patients with tuberculosis. J Nanjing Med Univ. 2014;14(05):354–358.
  • Buregyeya E, Mitchell EM. Tuberculosis infection control knowledge and attitudes among health workers in Uganda: a cross-sectional study. BMC Infect Dis. 2016;16(1). PMCID: PMCPMC4986352. doi:10.1186/s12879-016-1740-7
  • Kigozi NG, Heunis JC, Engelbrecht MC, van Rensburg APJ, van Rensburg HC. Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC Public Health. 2017;17. PMID: WOS:000412684800006. doi:10.1186/s12889-017-4825-3